SEC 13F Intelligence

Managers / Q2 2021 · view latest →

Bain Capital Public Equity Management II, LLC

CIK 0001768111 · 200 CLARENDON STREET, BOSTON, MA, 02116 · 6175162000

Reported Value
$2.3B
Q2 2021
Positions
51
Filings on Record
30
2019–present window
Filed
Aug 16, 2021
original filing

Summary

Bain Capital Public Equity Management II, LLC reported $2.3B in U.S.-listed holdings across 51 positions for Q2 2021.

Its largest position, AMZN, represents 8.7% of the portfolio.

Compared with Q1 2021, the fund opened 13 new positions and exited 23.

Portfolio Metrics

Turnover
+30.2%
vs prior filed quarter
Top-10 Concentration
+54.8%
share of reported value
Largest Position
+8.7%
Amazon Com
New / Exited
13 / 23
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $124MQ1 ’19Q2 ’19: $1.1BQ3 ’19: $1.1BQ4 ’19: $1.1BQ1 ’20: $854MQ1 ’20Q2 ’20: $1.3BQ3 ’20: $1.5BQ4 ’20: $2.0BQ1 ’21: $2.4BQ1 ’21Q2 ’21: $2.3BQ3 ’21: $2.9BQ4 ’21: $3.0BQ1 ’22: $3.1BQ1 ’22Q2 ’22: $2.0BQ3 ’22: $1.9BQ4 ’22: $1.8BQ1 ’23: $1.8BQ1 ’23Q2 ’23: $1.9BQ3 ’23: $2.1BQ4 ’23: $2.4BQ1 ’24: $2.5BQ1 ’24Q2 ’24: $2.4BQ3 ’24: $2.3BQ4 ’24: $2.2BQ1 ’25: $1.3BQ1 ’25Q2 ’25: $2.1BQ3 ’25: $2.1BQ4 ’25: $62MQ1 ’26: $0Q1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 83.7%Other: 7.7%ADR: 5.9%Tracking Stk: 2.5%ETP: 0.1%
  • Common Stock · 83.7% · $2.0B
  • Other · 7.7% · $181M
  • ADR · 5.9% · $138M
  • Tracking Stk · 2.5% · $58M
  • ETP · 0.1% · $3M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
STNESTONECO LTDNEW+1.32M1.32M+$89M$89M
FOURSHIFT4 PMTS INCNEW+667.3K667.3K+$63M$63M
LIBERTY MEDIA CORP DELNEW+1.21M1.21M+$58M$58M
NYTNEW YORK TIMES CONEW+1.10M1.10M+$48M$48M
GLOBAL E ONLINE LTDNEW+552.6K552.6K+$32M$32M
ARCTOS NORTHSTAR ACQUIS CORPNEW+599.5K599.5K+$6M$6M
XLFSELECT SECTOR SPDR TRNEW+16.5K16.5K+$976,000$976,000
SOARING EAGLE ACQUISITION CONEW+126.4K126.4K+$418,000$418,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2021

41 positions (from 42 filing rows — )
#IssuerClass% PortfolioValueShares
1AMZNAMAZON COM INChistory →COM8.69%$203M59.1K
2CCKCROWN HLDGS INChistory →COM7.73%$181M1.77M
3EXPEEXPEDIA GROUP INChistory →COM NEW6.21%$145M886.9K
4NOWSERVICENOW INChistory →COM5.80%$136M246.6K
5MSFTMICROSOFT CORPhistory →COM4.81%$112M415.2K
6SBNYSIGNATURE BK NEW YORK N Yhistory →COM4.71%$110M448.0K
7SCHWSCHWAB CHARLES CORPhistory →COM4.70%$110M1.51M
8EQHEQUITABLE HLDGS INChistory →COM4.46%$104M3.42M
9STZCONSTELLATION BRANDS INChistory →CL A3.89%$91M389.0K
10STNESTONECO LTDhistory →COM CL A3.79%$89M1.32M
11IBNICICI BANK LIMITEDhistory →ADR3.74%$87M5.11M
12HORIZON THERAPEUTICS PUB LSHS3.55%$83M887.3K
13ANAPLAN INCCOM3.42%$80M1.50M
14GOOGLALPHABET INChistory →CAP STK CL A3.34%$78M32.0K
15FISVFISERV INChistory →COM3.24%$76M707.9K
16FIVNFIVE9 INChistory →COM3.05%$71M388.7K
17DRVNDRIVEN BRANDS HLDGS INChistory →COM3.03%$71M2.29M
18FOURSHIFT4 PMTS INChistory →CL A2.68%$63M667.3K
19LESLIES INCCOM2.53%$59M2.15M
20LIBERTY MEDIA CORP DELCOM SER C FRMLA2.49%$58M1.21M
21EYENATIONAL VISION HLDGS INChistory →COM2.44%$57M1.12M
22NYTNEW YORK TIMES COhistory →CL A2.06%$48M1.10M
23SNYSANOFIhistory →SPONSORED ADR1.37%$32M610.0K
24GLOBAL E ONLINE LTDSHS1.35%$32M552.6K
25LIGHTSPEED POS INCSUB VTG SHS1.27%$30M353.7K
26BCRXBIOCRYST PHARMACEUTICALS INChistory →COM1.06%$25M1.56M
27UBERUBER TECHNOLOGIES INChistory →COM0.97%$23M450.2K
28IMCRIMMUNOCORE HLDGS PLChistory →ADS0.79%$19M474.6K
29HEALTHCOR CATALIO ACQU CORPCL A SHS0.57%$13M1.35M
30AFFIMED N VCOM0.45%$11M1.24M
31IQVIQVIA HLDGS INCCOM0.39%$9M38.0K
32OMEROMEROS CORPCOM0.27%$6M425.8K
33ARCTOS NORTHSTAR ACQUIS CORPSHS CL A · *W EXP 99/99/9990.26%$6M749.4K
34CYTKCYTOKINETICS INCCOM NEW0.23%$5M267.3K
35CURIS INCCOM NEW0.16%$4M467.4K
36ARYA SCIENCES ACQU CORP IVCL A0.14%$3M298.3K
37DVAXDYNAVAX TECHNOLOGIES CORPCOM NEW0.09%$2M219.8K
38DRAGONEER GROWTH OPPORTUN CO*W EXP 08/18/2020.03%$780,000387.0K
39SOARING EAGLE ACQUISITION CO*W EXP 02/23/2020.02%$418,000126.4K
40YUMANITY THERAPEUTICS INCCOM0.02%$356,00030.5K
41AUSTERLITZ ACQUISITION CORP*W EXP 02/19/2020.00%$71,00055.6K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$01May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$62M3Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$2.1B21Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$2.1B24Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$1.3B16May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$2.2B27Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$2.3B33Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$2.4B35Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$2.5B29May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$2.4B29Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$2.1B31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$1.9B32Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.8B31May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.8B30Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.9B35Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$2.0B39Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$3.1B43May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$3.0B45Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$2.9B54Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$2.3B51Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$2.4B61May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$2.0B43Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.5B43Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.3B45Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$854M39May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.1B38Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.1B52Feb 12, 2020RESTATEMENTchanges · EDGAR ↗
Q2 2019$1.1B56Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$124M10May 15, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.